pilocarpine has been researched along with Diabetes Mellitus, Type 2 in 5 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epilepsy is one of the most common neurological disorders affecting most social, economic and biological aspects of human life." | 5.72 | Treatment of pilocarpine-induced epileptic seizures in adult male mice. ( Abdelbasset, WK; Huldani, H; Jalil, AT; Jasim, SA; Margiana, R; Mohammad, HJ; Ridha, HS; Rudiansyah, M; Yasin, G, 2022) |
| "Epilepsy is one of the most common neurological disorders affecting most social, economic and biological aspects of human life." | 1.72 | Treatment of pilocarpine-induced epileptic seizures in adult male mice. ( Abdelbasset, WK; Huldani, H; Jalil, AT; Jasim, SA; Margiana, R; Mohammad, HJ; Ridha, HS; Rudiansyah, M; Yasin, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelbasset, WK | 1 |
| Jasim, SA | 1 |
| Rudiansyah, M | 1 |
| Huldani, H | 1 |
| Margiana, R | 1 |
| Jalil, AT | 1 |
| Mohammad, HJ | 1 |
| Ridha, HS | 1 |
| Yasin, G | 1 |
| Datta, S | 1 |
| Biswas, NR | 1 |
| Saxena, R | 1 |
| Deepak, KK | 1 |
| Menon, V | 1 |
| Garg, SP | 1 |
| Tandon, R | 1 |
| Mourad, JJ | 1 |
| des Guetz, G | 1 |
| Debbabi, H | 1 |
| Levy, BI | 1 |
| Chen, F | 1 |
| Nakashima, N | 1 |
| Kimura, I | 1 |
| Kimura, M | 1 |
| Asano, N | 1 |
| Koya, S | 1 |
| Levy, DM | 1 |
| Rowley, DA | 1 |
| Abraham, RR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Exploratory Study. Endothelial Function and Vascular Biomarkers: Predictive Indicators of the Progression From Gestational Hypertension to Preeclampsia?[NCT04520048] | 110 participants (Anticipated) | Interventional | 2023-08-24 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for pilocarpine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Treatment of pilocarpine-induced epileptic seizures in adult male mice.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Epilepsy; Humans; Male; Mice; Pilocarpine; Pioglit | 2022 |
Ocular and cardiovascular autonomic function in diabetic patients with varying severity of retinopathy.
Topics: Adult; Autonomic Nervous System Diseases; Cardiovascular System; Case-Control Studies; Diabetes Mell | 2005 |
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation.
Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozocin-diabetic mice.
Topics: Amino Sugars; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Rel | 1995 |
Changes in cholinergic sweat gland activation in diabetic neuropathy identified by computerised sweatspot analysis.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Eccrine Glands; | 1991 |